Vitrolife AB (publ) (STO:VITR)

Market Cap	18.66B
Revenue (ttm)	3.54B
Net Income (ttm)	455.00M
Shares Out	135.42M
EPS (ttm)	3.35
PE Ratio	41.13
Forward PE	31.71
Dividend	1.10 (0.80%)
Ex-Dividend Date	Apr 30, 2025

Volume	157,393
Average Volume	61,397
Open	137.80
Previous Close	136.90
Day's Range	136.00 - 138.90
52-Week Range	131.10 - 268.00
Beta	1.74
RSI	50.65
Earnings Date	Oct 23, 2025

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Employees: 1,169
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: VITR